CDK1 serves as a potential prognostic biomarker and target for lung cancer

por Li, Mingyao, He, Fenyi, Zhang, Zhanchun, Xiang, Zhenfei, Hu, Danfei
Publicado 2020

Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy

por Xiang, Zhenfei, Shen, Erdong, Li, Mingyao, Hu, Danfei, Zhang, Zhanchun, Yu, Senquan
Publicado 2021

Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Car...

por Wang, Chen, Tong, Jiaqi, Tang, Mengqiu, Lu, Yunyun, Liang, Gaofeng, Zhang, Zhanchun, Chen, Tian
Publicado 2021

Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib

por Tang, Mengqiu, Song, Chao, Zhang, Yaowen, Xu, Xiaoyu, Wang, Chen, Zhang, Zhanchun, Chen, Tian
Publicado 2021

Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Their Variations as a Basis for a Prediction Model in Advanced NSCLC Patients Receiving Anlotinib

por Chen, Tian, Song, Chao, Liang, Gaofeng, Xu, Xiaoyu, Wang, Chen, Zhang, Zhanchun, Tang, Mengqiu
Publicado 2022

Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study

por ZHU, Lucheng, Zou, Changlin, Zhang, Zhanchun, Wang, Jianfang, Yang, Li, Rao, Chuangzhou, Yang, Zhiping, Liang, Jiafeng, Xia, Bing, Shenglin, M. A.
Publicado 2021